PRMT5 and colorectal carcinoma: In support of this relationship, meta-analysis of RNA-seq data from TCGA showed that PRMT5 is significantly upregulated in CRC patient samples compared to the non-cancerous specimens, as previously seen for NAA40 (compare Figs. 6b to 1c).